Buck Wealth Strategies’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-10
Closed -$1.03K 250
2023
Q3
$1.03K Hold
10
﹤0.01% 333
2023
Q2
$1.22K Hold
10
﹤0.01% 251
2023
Q1
$1.54K Buy
+10
New +$1.65K ﹤0.01% 187

Other funds holding MRNA

Buck Wealth Strategies's MRNA Position: Q4 2023 in Review

Buck Wealth Strategies sold out of Moderna (MRNA) in Q4 2023, closing a stake of 10 shares — an estimated $1.03K sold.

Buck Wealth Strategies first reported a position in MRNA in Q1 2023 and held it in 3 quarters. The position peaked at $1.54K in Q1 2023. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Buck Wealth Strategies reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • Buck Wealth Strategies sold 10 Moderna shares in Q4 2023, an estimated $1.03K.
  • Buck Wealth Strategies first reported a position in Moderna in Q1 2023 and held it in 3 quarters.
  • Buck Wealth Strategies's Moderna position peaked at $1.54K in Q1 2023.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Buck Wealth Strategies's 13F filing for Q4 2023, filed 23 Jan 2024.